412
Participants
Start Date
May 31, 2024
Primary Completion Date
September 5, 2025
Study Completion Date
September 5, 2025
Salbutamol HFA-134a
100 microgram (μg) (ex-valve) at 30-second intervals per actuation
Salbutamol HFA-152a
100 μg (ex-valve) at 30-second intervals per actuation
GSK Investigational Site, La Plata
GSK Investigational Site, Botany
GSK Investigational Site, Kanwal
GSK Investigational Site, Coffs Harbour
GSK Investigational Site, Iloilo City
GSK Investigational Site, Spearwood
GSK Investigational Site, Panama City
GSK Investigational Site, Panama City
GSK Investigational Site, Torino
GSK Investigational Site, Brooklyn
GSK Investigational Site, Pathum Thani
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Athens
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Philadelphia
GSK Investigational Site, Pottstown
GSK Investigational Site, Milan
GSK Investigational Site, Tradate VA
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Pozuelo de AlarcOn Madr
GSK Investigational Site, Asheville
GSK Investigational Site, Spartanburg
GSK Investigational Site, Union
GSK Investigational Site, Marbella
GSK Investigational Site, Benalmádena
GSK Investigational Site, Rock Hill
GSK Investigational Site, Stonecrest
GSK Investigational Site, Rincon
GSK Investigational Site, DeLand
GSK Investigational Site, Winter Park
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Aventura
GSK Investigational Site, Plantation
GSK Investigational Site, Clearwater
GSK Investigational Site, Naples
GSK Investigational Site, Padua
GSK Investigational Site, Verona
GSK Investigational Site, Olive Branch
GSK Investigational Site, Louisville
GSK Investigational Site, Larissa
GSK Investigational Site, Owensboro
GSK Investigational Site, Dublin
GSK Investigational Site, Cincinnati
GSK Investigational Site, Florence
GSK Investigational Site, Minneapolis
GSK Investigational Site, Minneota
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Columbia
GSK Investigational Site, Strasbourg
GSK Investigational Site, Foggia
GSK Investigational Site, Tomball
GSK Investigational Site, Sugar Land
GSK Investigational Site, Amiens
GSK Investigational Site, Napoli
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Poitiers
GSK Investigational Site, Henderson
GSK Investigational Site, Créteil
GSK Investigational Site, San Mateo
GSK Investigational Site, Argenteuil
GSK Investigational Site, Pontoise
GSK Investigational Site, Medford
GSK Investigational Site, North Hollywood
GSK Investigational Site, Fall River
GSK Investigational Site, Jersey City
GSK Investigational Site, Riverdale
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Mendoza
GSK Investigational Site, Ajax
GSK Investigational Site, Brampton
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Windsor
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Cannes
GSK Investigational Site, Cagliari
GSK Investigational Site, Roma
GSK Investigational Site, Panama City
GSK Investigational Site, Bialystok
GSK Investigational Site, Bielsko-Biala
GSK Investigational Site, Chorzów
GSK Investigational Site, Elblag
GSK Investigational Site, Katowice
GSK Investigational Site, Ostrowiec Świętokrzyski
GSK Investigational Site, Płock
GSK Investigational Site, Tarnów
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Bebington
GSK Investigational Site, Cambridgeshire
GSK Investigational Site, Corby
GSK Investigational Site, Greater Manchester
GSK Investigational Site, Guisborough
GSK Investigational Site, Hounslow
GSK Investigational Site, Rhyl
GSK Investigational Site, Uttoxeter
Lead Sponsor
GlaxoSmithKline
INDUSTRY